Is there a prostate cancer genomic profile that can be helpful for men with prostate cancer who are not receiving chemotherapy?
Unfortunately, we do not yet have a tumor genomic profile that could help those who are not receiving chemotherapy. Our research at Duke University Medical Center aims to understand high risk, localized prostate cancer and metastatic, hormone-refractory prostate cancer by explaining the characteristics and behavior of individual tumors. In the future, we may expand our research to include other types of prostate cancer. To find clinical trials at a hospital near you or to learn more about cancer, please call the National Cancer Institute information line: 1-800-4-CANCER.
Related Questions
- Is there a prostate cancer genomic profile that can be helpful for men with prostate cancer who are not receiving chemotherapy?
- Can a genomic profile predict the likelihood of prostate cancer in someone with a family history of prostate cancer?
- Can a prostate cancer genomic profile predict if the tumor will recur?
